ACCU-CHEK Connect Diabetes Management App; Instruction Manual Designed to transfer data for di...

FDA Device Recall #Z-1369-2015 — Class II — October 30, 2014

Recall Summary

Recall Number Z-1369-2015
Classification Class II — Moderate risk
Date Initiated October 30, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diabetes Care, Inc.
Location Indianapolis, IN
Product Type Devices
Quantity The application has been downloaded total of 644 times (Italy-219, South Africa-24, Germany-401) and there are 113 bolus advice activations.

Product Description

ACCU-CHEK Connect Diabetes Management App; Instruction Manual Designed to transfer data for diabetes management.

Reason for Recall

Roche Diabetes Care has become aware of an issue with the Accu-Chek Connect diabetes management app that could potentially lead to inaccurate bolus advice being provided to the user. A thorough investigation of the situation revealed that this issue may occur if the user changes the screen orientation of the phone from portrait to landscape or vise versa while looking at the Bolus Advisor or Carb

Distribution Pattern

There are no US distributors as the affected device is not marketed in the US. The affected device was distributed in Germany, Italy and South Africa. The application has been downloaded total of 644 times (Italy-219, South Africa-24, Germany-401) and there are 113 bolus advice activations.

Lot / Code Information

N/A

Other Recalls from Roche Diabetes Care, Inc.

Recall # Classification Product Date
Z-2174-2024 Class II Accu-Chek Guide (SC) Kit -Intended to quantitat... May 13, 2024
Z-1008-2022 Class II RocheDiabetes Care Platform Software version 2.... Mar 9, 2022
Z-2351-2021 Class II Accu-Chek Aviva Plus Test Strip, Blood Glucose ... Jul 28, 2021
Z-2354-2021 Class II Accu-Chek Inform II Test Strip, Whole Blood Glu... Jul 28, 2021
Z-2353-2021 Class II Accu-Chek SmartView Test Strip, Blood Glucose M... Jul 28, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.